Rhinomed (ASX:RNO) to initiate nation wide sleep study this Saturday night
Rhinomed (ASX:RNO) a Melbourne based sleep and respiratory technology company is pleased to advise that it will initiate a nation wide sleep trial this Saturday night.
Companies in the News
Biotech
Rhinomed Ltd (ASX:RNO) To Present at Master Investor UK Show
Rhinomed (ASX:RNO) is pleased to advise CEO Michael Johnson has been invited to provide the keynote address on the Rising Stars Stage at the 2015 Master Investor Show (www.masterinvestor.co.uk) to be held in London on 25th April, 2015.
Rhinomed Ltd (ASX:RNO) Mute Secures Australian Wholesale Pharmacy Distribution
Rhinomed (ASX:RNO) is pleased to announce it has secured Australian wholesale pharmacy distribution with Symbion, part of the trans-Tasman EBOS Group, for its Mute(R) snoring and sleep quality technology.
Compumedics Limited (ASX:CMP) DWL Secures Deal to supply its Doppler-Box technology to key military hospitals in China
Compumedics Limited (ASX:CMP) is pleased to announce that the Company's German--based, brain blood--flow Doppler-sonography division, Compumedics Germany GmbH, has secured a AUD$375K deal to supply its Doppler-Box technology to key military hospitals in China.
Regeneus Ltd (ASX:RGS) To Present at Regenerative Medicine Investor Day in New York
Regeneus Ltd (ASX:RGS) announced today that John Martin, CEO, will present at the 3rd Annual Regenerative Medicine Investor Day to be held Wednesday, March 25, 2015 in New York City.
Rhinomed Ltd (ASX:RNO) Investor Newsletter
Rhinomed Ltd (ASX:RNO) now has two products on the market. Having launched our first technology, Turbine(TM), into the Australian market for testing in January 2014, we have now released our new technology, Mute™ into the OTC snoring space.
Regeneus Ltd (ASX:RGS) Positive preclinical results for Progenza
Regenerative medicine company, Regeneus (ASX:RGS) announced today that it has successfully completed a preclinical study to support its first-in-human safety study of Progenza, its allogeneic, off-theshelf stem cell product for osteoarthritis (OA).
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
Social Media
